These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 21804160

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Respiratory syncytial virus market.
    Storey S.
    Nat Rev Drug Discov; 2010 Jan; 9(1):15-6. PubMed ID: 20043025
    [No Abstract] [Full Text] [Related]

  • 5. Management of infections caused by respiratory syncytial virus.
    Swedish Consensus Group.
    Scand J Infect Dis; 2001 Jan; 33(5):323-8. PubMed ID: 11440215
    [Abstract] [Full Text] [Related]

  • 6. [Prevention of respiratory syncytial virus infections with palivizumab].
    Ellingsen BB, Aase SA, Øymar K.
    Tidsskr Nor Laegeforen; 2003 Apr 03; 123(7):941-3. PubMed ID: 12737068
    [No Abstract] [Full Text] [Related]

  • 7. [Respiratory syncytial virus infections: measures in immunocompromised patients].
    Hirsch HH, Steffen I, Francioli P, Widmer AF.
    Praxis (Bern 1994); 2006 Jan 18; 95(3):61-6. PubMed ID: 16459735
    [Abstract] [Full Text] [Related]

  • 8. Management of respiratory syncytial virus infection.
    Kimpen JL.
    Curr Opin Infect Dis; 2001 Jun 18; 14(3):323-8. PubMed ID: 11964851
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. RSV disease--is there a role for prevention?
    Lenney W.
    Respir Med; 2001 Mar 18; 95(3):170-2. PubMed ID: 11266232
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Palivizumab (synagis): counting "costs" and values.
    Carter BS.
    Pediatrics; 2000 Nov 18; 106(5):1168-9. PubMed ID: 11185071
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Respiratory syncytial virus infections: characteristics and treatment.
    Chidgey SM, Broadley KJ.
    J Pharm Pharmacol; 2005 Nov 18; 57(11):1371-81. PubMed ID: 16259768
    [Abstract] [Full Text] [Related]

  • 17. [RSV-prophylaxis--to whom?].
    Lossius K.
    Tidsskr Nor Laegeforen; 2000 Sep 10; 120(21):2494. PubMed ID: 11070982
    [No Abstract] [Full Text] [Related]

  • 18. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation.
    Shah JN, Chemaly RF.
    Blood; 2011 Mar 10; 117(10):2755-63. PubMed ID: 21139081
    [Abstract] [Full Text] [Related]

  • 19. Prevention of respiratory syncytial virus infection in high risk infants.
    Prince AM, Jacobs RF.
    J Ark Med Soc; 2001 Oct 10; 98(4):115-8. PubMed ID: 11594047
    [Abstract] [Full Text] [Related]

  • 20. Respiratory syncytial virus: old challenges and new approaches.
    Chávez-Bueno S, Mejías A, Jafri HS, Ramilo O.
    Pediatr Ann; 2005 Jan 10; 34(1):62-8. PubMed ID: 15693217
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.